



High-throughput screening approaches and
combinatorial development of biomaterials using
microfluidics
Citation for published version (APA):
Barata, D., van Blitterswijk, C., & Habibovic, P. (2016). High-throughput screening approaches and
combinatorial development of biomaterials using microfluidics. Acta Biomaterialia, 34, 1-20.
https://doi.org/10.1016/j.actbio.2015.09.009





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Nov. 2021
Acta Biomaterialia 34 (2016) 1–20Contents lists available at ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /actabiomatReview articleHigh-throughput screening approaches and combinatorial development
of biomaterials using microfluidicsqhttp://dx.doi.org/10.1016/j.actbio.2015.09.009
1742-7061/ 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
q Part of the High Throughput Approaches to Screening Biomaterials Special Issue, edited by Kristopher Kilian and Prabhas Moghe.
⇑ Corresponding author.
E-mail address: p.habibovic@maastrichtuniversity.nl (P. Habibovic).
1 Current affiliation: Maastricht University, MERLN Institute for Technology-Inspired Regenerative Medicine, P.O. Box 616, 6200 MD Maastricht, The Netherlands.David Barata, Clemens van Blitterswijk 1, Pamela Habibovic ⇑,1
Department of Tissue Regeneration, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands
a r t i c l e i n f oArticle history:
Received 1 June 2015
Received in revised form 7 September 2015
Accepted 8 September 2015






Organ-on-chipa b s t r a c t
From the first microfluidic devices used for analysis of single metabolic by-products to highly complex
multicompartmental co-culture organ-on-chip platforms, efforts of many multidisciplinary teams around
the world have been invested in overcoming the limitations of conventional research methods in the
biomedical field. Close spatial and temporal control over fluids and physical parameters, integration of
sensors for direct read-out as well as the possibility to increase throughput of screening through paral-
lelization, multiplexing and automation are some of the advantages of microfluidic over conventional, 2D
tissue culture in vitro systems. Moreover, small volumes and relatively small cell numbers used in experi-
mental set-ups involving microfluidics, can potentially decrease research cost. On the other hand, these
small volumes and numbers of cells also mean that many of the conventional molecular biology or bio-
chemistry assays cannot be directly applied to experiments that are performed in microfluidic platforms.
Development of different types of assays and evidence that such assays are indeed a suitable alternative
to conventional ones is a step that needs to be taken in order to have microfluidics-based platforms fully
adopted in biomedical research. In this review, rather than providing a comprehensive overview of the
literature on microfluidics, we aim to discuss developments in the field of microfluidics that can aid
advancement of biomedical research, with emphasis on the field of biomaterials. Three important topics
will be discussed, being: screening, in particular high-throughput and combinatorial screening; mimick-
ing of natural microenvironment ranging from 3D hydrogel-based cellular niches to organ-on-chip
devices; and production of biomaterials with closely controlled properties. While important technical
aspects of various platforms will be discussed, the focus is mainly on their applications, including the
state-of-the-art, future perspectives and challenges.
Statement of Significance
Microfluidics, being a technology characterized by the engineered manipulation of fluids at the submil-
limeter scale, offers some interesting tools that can advance biomedical research and development.
Screening platforms based on microfluidic technologies that allow high-throughput and combinatorial
screening may lead to breakthrough discoveries not only in basic research but also relevant to clinical
application. This is further strengthened by the fact that reliability of such screens may improve, since
microfluidic systems allow close mimicking of physiological conditions. Finally, microfluidic systems
are also very promising as micro factories of a new generation of natural or synthetic biomaterials and
constructs, with finely controlled properties.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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It is now becoming increasingly recognized that in vitro cell cul-
ture experimental set-ups in the conventional tissue culture plas-
tics fall short in mimicking the natural in vivo microenvironment,
which is considered one of the reasons for their limited predictive
value. In addition to efforts required to overcome this issue, an
increasing need exists for higher throughput of screening in the
biomedical field, with the aim to accelerate the development of
new and improved medical treatments against lower costs. In the
field of pharmacology, high-throughput screening approaches
were implemented relatively early, however, a large gap has been
observed between the in vitro findings and the in vivo efficiency of
the treatment, which is, for at least in a part, due to the use of over-
simplistic conventional cell culture systems [1,2]. This gap
becomes even larger when biomaterials are introduced into the
system. Indeed, conventional cell culture platforms were devel-
oped to study cell–cell interactions and cell responses to soluble
stimuli such as growth factors, antibiotics, small molecules, etc.
Interestingly, such platforms were implemented into biomaterials
research field without significant modifications. As a consequence,
many have shown that results on cell–material interactions
obtained in such simplistic systems are also poorly representative
of the interactions that occur in vivo [3]. These issues with research
systems having poor predictability will undoubtedly continue to
exist, since state-of-the-art solutions for clinical problems, such
as regenerative strategies for damaged and diseased organs and
tissues, are gaining on complexity. Indeed, modern regenerative
solutions often include combined contributions from biomaterials
of different types, cell- and tissue constructs, growth factors, etc.
On the other hand, our society is ageing, requiring the efficiency
of discovery of clinical treatments to be maintained at a high level.
To keep up with these scientific and societal developments, it is
therefore evident that efforts need to be invested in the develop-
ment of research systems that allow both faster and more reliable
screening for biomedical applications.
In the past 10 years, the wealth of developments in the field of
microfluidics has helped to establish a new set of standards in the
study of basic biological phenomena. Microfluidics is defined as the
science and technology of systems that process and manipulate
small (109–1018 L) amounts of fluids by using channels withdimensions from tens to hundreds of micrometers [4]. Platforms
based on microfluidics offer important advantages over classical
in vitro cell culture systems such as close temporal and spatial con-
trol over fluids and physical parameters, integration of sensors for
direct readout, and the possibility to increase throughput of
screening by utilizing parallelization, multiplexing and automa-
tion. Furthermore, the micrometer scale makes microfluidic sys-
tems unique for having features in the range of a single cell size,
which can be highly valuable in fundamental biological resarch,
provided that also readouts are scaled down and their sensitivity
reaches single cell resolution. Nevertheless, the validity of such
assays, or the evidence that they are at least as reliable as conven-
tional assays is needed for microfluidic platforms to be explored to
the maximum extent. Alternatively to development of new assays,
conventional analytical tools can be rendered applicable to
microfluidic systems by means of customized interfacing [5].
Apart from the assays, the platforms as such, including the
materials they are made from, and methods to produce them, need
to prove their value for biomedical research. In early microfluidic
systems for biomedical applications, rigid, inert materials such as
silicon and glass, directly inherited from the field of microelectron-
ics, reigned. However, current technology now allows the use of
biopolymers that can be microfabricated to detail, tuned in their
properties (e.g. stiffness, porosity, dielectric properties,
hydrophilicity) by chemical changes, and biochemically decorated
to better mimic the natural microenvironment [6]. These include
photo- or heat-curable polymers such as SU-8 epoxy, polyimide
photoresist, poly-dimethylsiloxane (PDMS) elastomer, as well as
thermoplasts such as polymethylmethacrylate, polycarbonate,
polystyrene, cyclic-olefin-copolymers and Teflon. Also the ever-
lasting discussion between the PDMS-land engineers and
polystyrenia kingdom biologists [7] has become further democra-
tised, as a consequence of an exponentially increasing availability
of complex materials that can be embedded in microfluidic
devices, the on-demand delivery of smart hydrogels, and the
nanometer-scale resolution printability of new scaffolding poly-
mers and bioinorganics.
In this review, we aim to provide an overview of advances in the
field of microfluidics that can aid biomedical research, with special
emphasis on the field of biomaterials. We will do so by describing
relevant examples of platforms that are developed with the aim of:
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screening, (2) mimicking of natural microenvironment ranging
from 3D hydrogel-based cellular niches to organ-on-chip devices;
and (3) production of a new generation of deliverable materials.2. Screening cellular responses in microfluidic systems
A growing interest in microfluidic systems is largely derived
from their proven versatility in biosensor applications. This multi-
disciplinary research field rapidly delivered point-of-care diagnos-
tic devices, which are predominantly based on transducer
mechanisms using biomolecules for sensitive and selective recog-
nition of analytes in the bioenvironmental or biological samples.
Oligonucleotides, peptides, enzymes and other bioprobes,
adsorbed on, covalently bonded to or otherwise connected with a
transducer, enable quantification of very small amounts of
biological (by)products, which are often difficult to detect. From
the very first applications of microfluidic devices, used to quantify
simple molecules in solutions, to a now mature field with
sophisticated devices using immobilised biomolecules in surface
transducers or suspended particles, a giant library of microfluidic
biosensors has been developed, meeting the needs of applications
at different levels [8–10].
A similar trend is observed in the development of microfluidic
devices specifically designed for biomedical research that incorpo-
rate cells with different levels of organization, with the aim to
study cellular responses to direct or indirect stimuli. In contrast
to classical tissue culture systems, where cells are exposed to bulk
materials or compounds in solution, microfluidic systems are use-
ful to study a response or interaction in greater detail, such as cell
attachment dynamics, material degradation in time, controlled
release, etc. [11–13]. Owing to a great parallelization potential,
microfluidic platforms are especially suitable for scaling-up of
screens while keeping the cost low, as a consequence of the low
volumes used. Such platforms can be developed by using the
strengths of microfluidics such as the possibility to create gradi-
ents, or by applying smart, multi-layered, complex fluid networks
that are specifically designed to assist assays with single cells, cell
monolayers, or aggregated or encapsulated cells. Furthermore, co-
culture can be easily performed through compartmentalization,
and combinatorial screens are possible whereby cells are simulta-
neously or subsequently exposed to two or more cues, of the same,
or different nature.
Nevertheless, multiplexing variables in a single fluidic layer
may be technically challenging when standard techniques, based
on one-step soft lithography are used, since fluidic channels cannot
cross or overlap. In such cases, other techniques, including 3D
printing [14–16], sequential overlapping layers [17–19], porous
or impermeable membranes [20–22] or valves [23] may help to
increase multiplicity of variables with higher level of freedom in
interconnectivity. Highly sophisticated operations and effective
use of the hierarchical structuring of microfluidic compartments
can also be achieved in centrifugal microfluidics [24].
2.1. Multiplexing variables into arrays
Different levels of complexity can be found in microfluidic
devices used for screening mammalian cell behavior upon expo-
sure to chemical or physical cues, ranging from single cells, via cell
monolayers, aggregates, or organoids to complete organ mimics.
2.1.1. Single cells
The study of single cells as individual source of information
has been predominantly enabled by geometrical and
hydrodynamic docking possibilities within microfluidic systems[25]. Furthermore, options of active cell trapping by means of
chemical, electrical or optical signals have also been described
[26]. Caging of cells can be used for precise delivery of nanoliter
volumes of nutrients or chemicals in time [27], for control over
cell–cell interactions [28] and subsequent analysis by constrained
lysis or non-destructive assays.
In single-cell platforms, only few hundreds of cells are required,
numbers that may be limiting when conventional analysis tech-
niques are applied. Faley et al. [29] described a microfluidic tech-
nique by which rare chronic myeloid leukemia CD34+
hematopoietic stem/progenitor cells could be individually immo-
bilized, followed through live imaging and assessed for protein
post-translational modification, and rapidly fixed in situ (Fig. 1A).
In line with this example, many biological assays in microfluidic
devices are imaging-based, although dynamic micro flow cytome-
ters have also been proposed [30]. Arrays of single-cells for screen-
ing of drugs can be particularly useful to track direct parameters
such as stem cell division symmetry, proliferation rate and motility
of cells, in addition to analysis of specific signaling pathways
[31,32]. For example, Wlodkowic et al. [33] induced mitochondrial
pathway for apoptosis by Staurosporine and monitored real-time
cellular events through increase of propidium iodine permeability,
apoptosis marker SYTO 62 and plasma membrane permeability
marker SYTOX Green.
Besides immobilized single cell arrays, encapsulation of single
cells into aqueous phase core droplets [34] was used to study
clonal heterogeneity in a cell population [35] or for coding of
compound libraries in high-throughput screenings [36].
2.1.2. Cell monolayers
Many conventional microfluidic systems, produced using soft
lithography fabrication methods, are particularly suitable for
studying cells in monolayer. Bio-analytical assays are performed
in micrometer-scale culture reservoirs, using continuous or peri-
odic perfusion regimes for media refreshment and reagent deliv-
ery. Commonly, designs of systems with multiple chambers
allow parallel readouts from individualized cell populations,
through independent experiments. For example, an integrated
microfluidic array plate was proposed by Dimov et al. [37] where
cytotoxicity, real-time nuclei acid sequence-based amplification
and immunofluorescent protein expression detection were per-
formed in parallel. Yang et al. [38] proposed a system creating a
3D hypoxic microenvironment that enabled efficient quantification
of human neuronal stem cell self-renewal and differentiation alter-
ations, as an alternative to 2D and 3D hydrogel-based macro cul-
ture systems. The authors used the system to evaluate the effect
of extracellular matrix (ECM) protein on the expression of a num-
ber of neuronal markers.
Scalability towards higher throughput and integration are
among the most important promises of microfluidic devices for
studying cell behavior. Additionally, along with minimization of
handling and destructive processing steps, efficient spatiotemporal
use of liquids is of substantial benefit. An example of a system in
which a number of these properties were integrated was given
by Wang et al. [39], showing coordinated use of valves, and appli-
cation of reporter plasmids encoding fluorescent proteins for fast
and non-destructive live readouts on active biochemical pathways.
2.1.3. Aggregates and spheroids
While multicellular bodies such as aggregates or spheroid-like
functional units can provide important information on cell–cell and
cell–ECM interactions, platforms enabling their culture and analysis
need to satisfy very specific requirements. As a result, available
options to comprehensively study the physiology and pathophysiol-
ogy of structures like islets of Langerhans, are limited. A successful
example was given by Nourmohammadzadeh et al. [40], who, based
Fig. 1. (A) Single cell microfluidic array allowing live imaging of the same single cell up to the investigation of intracellular protein phosphorylation. The device is suggested
to be useful for monitoring rare nonadherent cells as well as for correlating live cell events with immunocytochemical identification of cell signaling pathways. A schematic of
the microfluidic cell capture device (i); the process of successful and rapid in situ fixing, washing and staining of primary CML CD34+ stem/progenitor cells (ii) initially labeled
with TMRMmitochondrial stain (iv) for dead cells and cell nuclei. Reprinted with permission from Ref. [29]. Copyright 2011, AIP Publishing LLC. (B) Microfluidic trap array for
high-throughput analysis of vertically-oriented Drosophila melanogaster embryos. A scanning electron micrograph of the trap structure (scale bar, 100 lm) (i); a schematic
showing the imaging setup with in inset a representative confocal image of an embryo stained with Dorsal (D1), Twist (Twi), and phosphorylated ERK/MAPK (dpERK) (ii); a
schematic showing the embryo trapping process: from guidance into the trap (top), to vertical orientation with the flow around the embryo (middle) and fixation of the
embryo in place (bottom) (iii); a schematic of the dorsoventral patterning network, showing the feedforward loops activated by D1 (iv); confocal images of embryos
immunostained for D1 and Twi (v), D1 and dpERK (vi), and D1 and phospho-MAD (pMAD) (scalebar, 25 lm) (vii). Adapted with permission from Macmillan Publishers Ltd:
Nature Methods [43], copyright 2011.
4 D. Barata et al. / Acta Biomaterialia 34 (2016) 1–20on hydrodynamic trapping strategy coupled with islet microencap-
sulation in alginate microbeads demonstrated the hypoxia impair-
ment of intracellular calcium signaling, and mitochondrial
energetic and redox activity, with single islet resolution.
Microfluidic platforms have also been used in the study of
embryoid bodies, three-dimensional aggregates of pluripotent
stem cells, including their formation [41], development [42] and
eventual harvesting. An example of how microfluidics can provide
multi-dimensional control and delivery of asymmetric cues in the
formation of complex tissue is given by Chung et al. [43]. This plat-
form enabled study of polarization of embryoid bodies, through
actuating gradients of morphogens and real-time reporting on pat-
tern formation and development status (Fig. 1B.i–iii). More specif-
ically, the study investigated dorsal-to-ventral patterning
regulation (Fig. 1B.iv), a system dominated by feed forward loops.
While polarization over Twist (Twi) and Bone Morphogenetic Pro-
tein (BMP) gradients confirmed the existing knowledge, the plat-
form also enabled, for the first time, quantification of theMitogen Activated Protein Kinase (MAPK) phosphorylation gradi-
ent (Fig. 1B.v–vii).
2.1.4. Organisms
As a next step towards increasing complexity, microfluidic sys-
tems have also been applied in the study of complete organisms,
usually small living eukaryotes, in real-time experiments within
a time frame of minutes to hours. This type of experiments pro-
vides a more integrated view over the experimental setup, e.g.,
an overview of physiological events from uptake of a drug up to
its effect. Drosophila melanogaster or Caenorhabditis elegans
(C. elegans) are well-established model organisms, with rapid
life-cycles and easily generated pools of individuals [44,45]. Such
models are not only useful in developmental, genetic and disease
studies, but they may also aid development of organ- and tissue
regenerative strategies [44,46].
Recently, Levario et al. [47] presented a microfluidic trap
array to rapidly orient hundreds of Drosophila embryos. In
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used to induce morphogen concentration-dependent patterns.
The device enabled improved imaging and data acquisition of
dorsal–ventral gene patterning during embryogenesis, based on
the fact that, by default, the longer anterior–posterior axis is better
suited for microscopy setups, given the ellipsoidal shape of the
embryo. Carr et al. [48] used free living nematodes such as
C. elegans and parasitic Oesophagotomum dentatum for screening
drug resistance to anthelmintics in microfluidic devices. Given
the molecular biology tools available for detecting an altered
genotype due to this particular drug resistance, this microfluidic
chip offered the advantage of running numerous experiments in
parallel, and tracking changes real-time.
In other studies, whole organism microfluidic set-ups based on
C. elegans addressed questions as diverse as the worm’s lifespan
(important in ageing studies) through longitudinal measurements
by employing fluidic clamps [49] or difference between wild-
type and drug-resistant types by recording sensitive electropha-
ryngeograms [50]. Other model-organisms with strong interest in
regeneration have also been successfully used in microfluidic
approaches, such as the vertebrate zebrafish (Danio rerio) [51], or
the pluripotent cell rich planarians [52].
2.2. Gradients for screening
One distinct capability of microfluidics is the well-controlled
generation of gradients of species in solution. Gradients of mole-
cules can be generated in two ways, namely advection, being the
mass transport by the fluids bulk motion (flow-based gradient gen-
eration), or by diffusion, being the spreading of unequally dis-
tributed molecules by biased random walk induced by Brownian
motion (diffusion-based gradient generation). Two excellent
reviews have been published on the topic of gradient generation
by microfluidics. While Kim et al. [53] focused on technological
advancements in microfluidic gradient generators, dividing them
into flow-based and diffusion-based platforms, Berthier et al. [54]
discussed key applications of microfluidic gradients for biological
applications and elaborated on their future perspectives.
In microfluidics, as well as in materials science, gradients are
often described as a good technical resource of multiple conditions
within a relatively small area/volume. Importantly, while a gradi-
ent, by definition, should refer to a linear, or at least a continuous
progression of a variable, this term is frequently also used to
describe a step-wise progression, commonly referred to as discrete
gradient [55].
2.2.1. Soluble gradients
The ability to create gradients is particularly useful for studying
toxicity, cell migration or phenotype changes, upon exposure to a
compound in the solution. Spatiotemporal information of high res-
olution is thereby an important advantage. Several devices have
been proposed to study the effect of soluble species in cell culture
media delivered gradient-wise including assays for bacterial or
mammalian cell chemotaxis [56–58], cytotoxicity [59,60], tran-
scription factor translocations [61] and differentiation [62]. This
kind of platforms may enhance the power of assays as compared
to conventional experimental set-ups by significantly decreasing
the number of cells needed for robust and statistically relevant
readout. As an example of the use of microfluidics to create tightly
controlled gradients, Zhang et al. [63] presented a high-throughput
microfluidic platform designed to understand cancer metastasis by
monitoring epithelial–mesenchymal transition, which is a core
molecular program that enhances cell migration. In this set-up,
resistance of cells to antimetastatic drug gradients created through
microchannels was studied, either in their epithelial state or after
mesenchymal transition induced by a plasmid vector (Fig. 2A).Gopalakrishnan et al. [64] developed a real-time screening plat-
form for studying infection and immunological response through
tracking of cell migration. In this design, a chemokine gradient
was created, propagating from a source, and representing there-
with infectious foci (Mycobacterium avium), to study migration of
adherent macrophages, non-adherent T-cell hybridomas and den-
dritic cells. The system provided a decision-making monitoring
assay as a valuable tool for studying cellular migration and self-
organization. The authors asserted on the relevance of such a plat-
form as a non-animal alternative to address complex multicellular
biological processes as diverse as metastasis, immunotherapy, or
tissue remodeling.
Dynamic microfluidics-based cell culture chambers have been
developed to study response of single cells within a monolayer,
upon exposure to soluble cues, often using image-based cytometric
analyzes. In such systems, species in solution are delivered through
perfusive or diffusive fluidic regimes. Perfusion derived gradients
are generally generated by an array of hierarchically ramified
microchannels, upstream of the culture chamber [65,66]. A hydro-
dynamic junction can be used for diffusive mix, creating a progres-
sive gradient over the length of the resulting channel [60,66].
Diffusion-based gradients are a result of a source-sink arrangement
siding the chamber, whereby a directional movement by diffusion
is observed from the compartment containing higher concentra-
tion to the one with lower concentration [61,67]. Image-based
cytometry, which is frequently used for high-content assessment
of cell responses in such devices, often employs fluorescent assays
combined with automated microscopy image acquisition. For
example, Harink et al. [61] developed an end-point assay to quan-
tify translocation of hypoxia-inducible factor 1 alpha in cells
exposed to a diffusion-generated gradient in a closed, glass
microfluidic system. A translocation assay was also used by
Awwad et al. [65] in a long perfused cell culture chamber where
Chinese Hamster Ovary cells (CHO), hosting a reporter plasmid
with a fluorescent fusion protein human NF-jBp65 and pHyg, were
actuated by interleukin 1b gradients, demonstrating a linear
response in the concentration range of 0.005–0.1 ng/ml (Fig. 2B).
In contrast to the previous examples in which continuous gradi-
ents were created within the cell culture chamber, systems con-
taining multiple parallel compartments can alternatively benefit
from a discrete concentration gradient generator, derived from
hierarchically ramified fluidics, enabling fast serial dilutions to
non-connected sided compartments. This type of approach has
been used, for example, in cell cycle analysis [68] and cytotoxic
drug screening [69].
2.2.2. Surface-bound gradients
Besides application of microfluidics to generate gradients of sol-
uble species, several systems have been proposed to create
surface-bound gradients, which is particularly interesting for the
field of biomaterials. For example, various attempts have been
undertaken to mimic the microenvironment of the ECM and its
proteins, which are known for their role in developmental pattern-
ing, to stem cell niche support and regulation of the progression of
cancer and genetic diseases [70]. Various families of biomolecules,
including peptides, proteins, polymer brushes, electrolytes and
ECM-like polymers have been successfully applied on surfaces of
biomaterials in a gradient-wise manner. As suggested by Wu
et al. [71], different techniques to achieve such surface modifica-
tion can be categorized into top-down and bottom-up approaches.
The first group comprises techniques such as plasma modification
by selective etching of surfaces, electrical discharge, ultra-violet
irradiation and chemical degradation, whereas in the second group
techniques such as infusion (frequently used as dip-coating), diffu-
sion, micro contact printing, microfluidic lithography and electro-
chemistry can be found.
Fig. 2. (A) A high-throughput microfluidic device for monitoring mesenchymal migration that can be used as a tool to study cancer metastasis. Flowchart of the design,
fabrication and operation of the M-Chip to study cell migration and to screen migration inhibitors. Adapted with permission from Ref. [63], Copyright 2013 WILEY-VCH. (B)
Microfluidic device that generates a continuous concentration gradient of compounds in solution. A schematic of the device used to study single cell nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-jB) expression, with characterization of gradient profile at the entrance and exit of culture chamber and timelapse fluorescence
images of CHO/GFP-NFjBp65 cells upon exposure to high and low concentrations of Interleukin-1b. Reprinted with permission from Ref. [65], Copyright 2012 American
Chemical Society.
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biochemical functionalization of biomaterial surfaces, but also for
generating materials with spatially controlled physical properties,
such as stiffness, porosity, charge, roughness, etc. For example,
with the aim to mimic the natural ECM, Almodovar et al. [72]
deposited polymeric polyelectrolyte multilayer (PEM) films, char-
acterized by an anisotropic composition of topology gradients
(microbeads), biochemically decorated with cell adhesion mole-
cules (poly-(L)-lysine)-FITC, RGD) and stiffness gradients spanning
linearly over centimeters length (Fig. 3A). These gradients were
created by employing a sacrificial microfluidic device, and it was
shown that they could be used to control adhesion and spreading
of C2C12 myoblasts over the length of the gradient.
Many different techniques have been proposed for the pattern-
ing of surfaces by employing microfluidics, taking advantage of
laminar flow and intrinsic diffusive regimes of solutions and dilutespecies. Didar and Tabrizian [73] presented a system allowing
combinatorial delivery of soluble gradients over pre-activated sur-
faces, in which the molecule of choice could covalently attach to
the surface in a controlled manner, by controlling the perfused
solutions mixture. As a proof of concept, 2D gradients of Arg-
Glu-Asp-Val (REDV) and KRSR (Lysine-Arginine-Serine-Arginine)
peptides were distributed and immobilised along the length and
width of each channel, remaining functional under high shear
stresses (50 dyn/cm2), and subsequently validated for adhesion of
primary human umbilical vein endothelial cell (HUVEC).
Also surfaces of hydrogels, highly hydrated biomaterials, with
relevance in biomedical applications such as articular cartilage,
osteochondral and bone repair [74], can be successfully patterned
by means of microfluidics. For example, hydrodynamic flow focus-
ing has been successfully used for selective exposure and uptake of
tagged proteins into gels in a gradient fashion, as reported by
Fig. 3. (A) Microfluidic device for generating surface-bound biochemical and physical gradients of polyelectrolyte multilayer (PEM) films consisting of hyaluronan and poly(L-
lysine). Schematic representation of PEM film construction on a glass slide (i) and of formation of surface gradient of biomolecules on PEM films (ii). Reproduced from Ref. [72]
with permission of The Royal Society of Chemistry. (B) A system combining hydrogel engineering and microfluidics to generate tethered protein gradients on the surface of
poly(ethylene glycol) (PEG) hydrogels. Schematic of 2-step patterning process (i); stitched micrographs of a four-by-four gradient array of fluorescent-BSA–biotin (vertical)
and fluorescent Alexa488–hIgG (horizontal) gradients patterned on PEG gel using hydrodynamic flow focusing, magnification details and respective intensity profile graphs
(scale bar = 900 lm). Adapted from Ref. [75] with permission of The Royal Society of Chemistry.
Fig. 4. (A) Microfluidic device in which isolated cortical axons can be exposed to gradients of diffusing and substrate-bound molecules, permitting the simultaneous
application of piconewton forces to multiple individual growth cones via magnetic tweezers. A schematic representation of the three-compartmental (somatic, axonal, distal)
neuron culture device and the dipolar NdBFe magnet assembly (i); side view of the device showing the distance from the edge of the magnet assembly to the middle of the
axonal chamber (ii); top view with superposed micrograph of immunostained mouse cortical neurons fixed after 6 days of culture (iii); and detail showing b3-tubulin (green),
actin filaments (red), and nuclei (blue), acquired from the somatic and axonal chambers (iv–v); axonal growth cones with particles functionalized with neural cell adhesion
molecule antibody and time-lapse images of axon towing at 9.2 pN directed parallel to microchannels (arrow direction) (vi). Reprinted by permission from Macmillan
Publishers Ltd: Scientific Reports [80], copyright 2014. (B) Microfluidic platform for studying cell–matrix interactions upon simultaneous exposure to nanotopographical
surface features and flow. A schematic and optical image of the microfluidic platform and atomic force microscopy image of surface topography (left), and multichannel
confocal images of hMSCs upon culture under different conditions (right) with, in insets, enlarged images of paxillin arrangement. Adapted from [83] with permission of The
Royal Society of Chemistry. (C) A microfluidic device that enables generation of a stable, linear and diffusive chemical gradients over a hydrogel with a well-defined stiffness
gradient. A schematic showing diffusive and stiffness gradients arrangements within the microfluidic device (i–iv) and details of device assembly (v). Adapted from Ref. [85]
with permission of The Royal Society of Chemistry. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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hydrogels containing PEG-tethered NeutrAvidin/ProteinA could
be on-demand patterned by various gradient profiles of biomole-
cules, including the formation of surface-bound overlapping
gradients. Proof-of-concept was provided by immobilization of
leukemia inhibitory factor (LIF) on PEG-ProteinA films, successfully
sustaining colony formation of embryonic stem cells while
retaining their pluripotency (Fig. 3B).
2.3. Combinatorial screening
As mentioned before, a particularly important advantage of
microfluidics-based systems above other screening systems is their
integration capability, allowing multiplexing of variables of the
same or different nature within a single platform. Ranging from
relatively simple combinatorial mixing to more sophisticated mul-
tivariable devices [76–78], such systems enabled analyzes that
would otherwise not be possible. Examples include systems to
study cross effects of fluidic shear stress and mechanical displace-
ment [79], exposure to chemical gradients and electromagnetic
stimulation [80], surface-bound and compounds in solution [72],
among many others. For example, Li et al. [81] presented a dual
system in which chemical gradients and electrical fields co-exist,
using it to gain fundamental knowledge on the effects of compet-
ing chemoattractant gradients and direct current electric fields
on cell migration. Such a system may aid development of novel
therapeutic strategies for cell trafficking-mediated diseases, or
for understanding physiological processes common in autoim-
mune diseases, cancer, and wound healing, where electrical com-
ponents are used to remotely orient cellular processes in tissues.
In an attempt to find optimal culture microenvironment for
CHO-K1 cells in a perfused culture chamber, Hattori et al. [82]
developed a microfluidic platform in which combined effects of
ECM proteins collagen, fibronectin and laminin, that were used
as a substrate, and soluble medium factors were studied.
Kilinc et al. [80] described a microfluidic device in which iso-
lated cortical axons were exposed to both diffusive gradients and
substrate-bound chondroitin sulfate proteoglycans (CSPG). Super-
paramagnetic microbeads, functionalized with an antibody against
neural CAM, targeting axonal growth cones, under simultaneous
application of piconewton (pN) forces by magnetic tweezers, were
shown to drive elongation of individual growth cones. Interest-
ingly, parallel towing of axons towards inhibitory environments,
representative of the glial scar, where regenerating axons face
repellent surfaces, suggested that mechanochemical stimulation
coupled with directed inhibition of motor proteins and ROCK path-
way may be a promising therapeutic approach for the repair of the
damaged central nervous system (Fig. 4A). Also addressing cell
growth and adhesion, Yang et al. [83] demonstrated that orienta-
tion and deformation of cell cytoskeleton and nuclei in human
mesenchymal stem cells (hMSCs) could be regulated through the
interplay of both nanotopography and fluid shear stress (Fig. 4B).
Other examples of integrated platforms that take benefit from
engineered gradient profiles are the ones designed to study oxygen
tension effects, for example as a means to assess cellular responses
to hypoxic conditions. Wang et al. [84] integrated oxygen and
chemical concentration gradients in a single device to assess the
efficiency of antitumor drugs tirapazamine and bleomycin on
human lung adenocarcinoma A549 cells and human cervical carci-
noma HeLa cells. The authors demonstrated a dose-dependent via-
bility decrease induced by the drugs, and a hypoxia-induced
cytotoxicity of tirapazamine.
In the study by Garcia et al. [85] a hydrogel substrate with stiff-
ness varying in a gradient-wise manner, which was achieved using
a sliding-mask photopolymerization process, was combined with a
fluidic assembly that enabled generation of overlapping gradientsof hepatocyte growth factor in a solution, over the substrate. Com-
bined effects of substrate stiffness and growth factor concentra-
tions at different values were studied by looking at epithelial
scattering of MDCK cells, elegantly demonstrating the power of
gradients for screening (Fig. 4C).
In addition to systems exploring simultaneous effects of vari-
ables of different nature, control over fluidic regimes also allows
for combinatorial screening of two or more compounds in the solu-
tion. Simple injection of concurrent flows can be used to create
complex matrices of concentrations, useful in dose–response drug
screening of two components. Kim et al. [86], for example,
described a programmable microfluidic cell array in which gradi-
ents of concentrations and 64 pair-wise combinations could be cre-
ated on-chip. This device was used to screen and optimize
chemotherapeutic treatment against PC3 prostate cancer cells.3. Biomimetic microenvironments
Besides the so far highlighted possibilities of microfluidic tech-
nology to increase throughput of screening through parallelization
and integration, expectations are at least as high when it comes to
creating microenvironments that closely resemble the natural sys-
tems. Through compartmentalization in 3D, resulting from various
multilayering options, initially developed within the microelec-
tromechanical system (MEMS) field, complex microenvironments
can now be created relatively easily at low cost. Systems allowing
multi-layered cell (co)-culture, with spatiotemporal control over
nutrient- and soluble cues, and simultaneous incorporation of
physical cues can now be realized [87]. These technological devel-
opments, however, are only useful when supported by fundamen-
tal understanding of the natural systems. Indeed, in vitro platforms
are always a mimic of the natural system, regardless of their com-
plexity. It is therefore important to make the right choice of the
function to be mimicked, as justification of this choice will eventu-
ally determine whether a system is considered valuable (i.e. truly
predictive of the in vivo situation) or not.3.1. Application of 3D matrices
As mentioned earlier, hydrogels are remarkably useful as deliv-
ery vehicles for factors of interest, as well as facilitators of cell
growth and ECM production. This application versatility, combined
with relative ease of handling through microfluidic channels justi-
fies the widespread use of hydrogels to realistically recreate ‘‘arti-
ficial niches” in microfluidic systems, either in the form of 3D
microfabricated compartments, or in droplets.
Various types of hydrogels have been processed in microfluidic
systems [88], with collagen [89–92], PEG [1,93,94], agarose [95],
fibrin [92,96], and PEGDA [97,98] being most commonly used as
single compounds or in mixtures.
Hydrogels also allow 3D entrapment of molecules, for example
in a gradient fashion that would otherwise be added to bulk solu-
tion. As summarized by Malda et al. [99], different strategies are
available for hydrogel gelation, allowing shaping of structures
either by physical (ionic, stereocomplex, thermal) or chemical
(UV, wet-chemical) crosslinking methods. Structured, patterned
or gradient-wise decorated hydrogels, of particular interest in
combination with microfluidics, are predominantly obtained by
using photo-polymerization [98,85] or thermal crosslinking
[13,93,96].
For example, Ostrovidov et al. [97] described controlled injec-
tion of the PEGDA hydrogel precursors into the microfluidic device
from independent inlets and demonstrated formation of a gradient
by means of incorporation of a fluorescent model molecule. Upon
creation of a stable gradient, photopolymerization was used to
Fig. 5. (A) A platform for anticancer drug screening employing fluorescent detection of hydrogel encapsulated cells in microchannels. Schematic diagram of the process of
platform generation (i–iv); optical images (v) and fluorescent live (green)/dead (red) images (vi) showing geometrically defined hydrogels upon UV crosslinking containing
HepG2 cells (cylinders) and A549 cells (rectangles) (top) with magnification of one array (bottom). Adapted from Ref. [100], Copyright 2010, with permission from Elsevier.
(B) Patterning of 3D ECM with soluble gradients by microfluidics-ported microchannels. Schematic overview of the fabrication process based on the use of gelatin templating
and sacrificial removal after collagen gelation (i); schematic of a model tissue containing multiple endothelialized tubules (pink and green) traversing a stromal compartment
containing mesenchymal cells (blue). Dashed line indicates the presence of a glass surface (ii); confocal image of 3T3s cells nuclei (blue) and two populations of HUVECs (pink
and green) incorporated directly into the gel and seeded along the channels, respectively (iii); spreading and proliferation of HUVEC cells, resulting in confluent monolayers
inside the open microfluidic channels (iv). Adapted from Ref. [89] with permission of The Royal Society of Chemistry. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
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release profiles and the study of the toxic effect upon loading with
okadaic acid. Similarly, Gao et al. [100] employed photolithography
to geometrically encapsulate human heptanoma HepG2 and
human lung epithelial A549 cells in a PEG hydrogel inside a
microfluidic device that was used to study apoptosis upon expo-
sure to anticancer drugs (Fig. 5A).
While hydrogels are mainly used as 3D cell culture substrates
and biomolecule carriers integrated into a microfluidic system, a
number of studies exists in which hydrogels were used for defining
the microfluidic structure. This was, for example, well-illustrated
by Baker et al. [89], who used an ECM gel precursor solution and
casted it over a sacrificial gelatin mold to create the fluidic com-
partments, followed by gelation and dissolution of the gelatin.
The 3D ECM microfluidic device proved to be perfused, leakage-free, and able to accommodate cell culture. Moreover, the matrix
easily enabled diffusive gradients from the channels through the
mesh as well as co-culture, with fibroblasts embedded in the
matrix and HUVECs in the channels, mimicking the vascular
endothelium (Fig. 5B).
3.2. Compartmentalization and networking
Compartmentalization is a key factor in the use of engineered
microfluidic systems aiming at mimicking complex, organ-like
microenvironments. From spatially segmented contiguous cell cul-
ture chambers, to complex tri-dimensionally ordered compart-
ments, the number of possible designs is endless. The new
advent of organ-on-chip has initiated important discussions
regarding relevance of such systems in terms of resemblance of
Fig. 6. (A) Engineered living microvascular networks in 3D collagen matrix by employing microfluidics. Schematic cross-sectional view of a detail of microvascular network
illustrating morphology and barrier function of endothelium (i-i), endothelial sprouting (i-ii), perivascular interaction (i-iii) and blood perfusion (i-iv). Arrows point in low
direction; Z-stack projection of horizontal confocal sections of endothelialized microfluidic vessels of overall network (ii-i) and a corner (ii-ii). Fluorescent staining for CD31
(red), nuclei (DAPI, blue). Scale bar: 100 lm. Adapted from Ref. [13]. (B) Platform based on hanging-drop technology comprising multifunctional complex microfluidic
networks between multicellular spheroids. Three essential handling steps of the experimental set-up (close-up views indicate key areas): cell seeding, liquid connectivity at
horizontal perfusion channel and gradient flow generation through the array (i); micrograph overlay (bright-field and green fluorescence) of spheroids formed after 68 h in
flow conditions with varying fetal bovine serum concentrations (ii); photograph of the interconnected hanging-drops device filled with food-dye-colored deionized water
showing equal-size drops (iii). Adapted from Ref. [112] with permission of The Royal Society of Chemistry. (C) Compartmentalized neuronal arraying microfluidic circuits for
generating neuronal networks with low cell numbers. A schematic of the water masking concept with micropillars pinning the water meniscus in place for plasma stencilling
to include aligned biomaterial patterns inside the microfluidic device (i); highly interconnected human SH-SY5Y neuroblastoma cell line co-cultures in 2-compartment (ii)
and 3-compartment (iii) system. In the 3-compartment system, a patterned poly(lysine) surface was only provided in the central compartment; a continuous poly(lysine)
coating was used in the flanking compartments. Neurons and neurite outgrowth was visualized by immunostaining for b(III)-tubulin following 5-day culture. Adapted by
permission from Macmillan Publishers Ltd: Nature Communications [120], copyright 2014. (D) A microfluidic model system mimicking human microtissues with
interconnected vascular networks. Microfluidic configuration and the simulated pressure field of the multi-microtissue platform with a dominated hydraulic resistor Rn+1 (i);
fluorescence microscopy images of 5 developed human microtissues, where microvascular network and nuclei were labeled with CD31 (green) and DAPI (blue), respectively.
Adapted from Ref. [94] with permission of The Royal Society of Chemistry. (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article.)
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for the in vivo situation, which, eventually, could significantly
change the way research is done in many biomedical fields, rang-
ing from drug screening to regenerative medicine, as recently
reviewed in detail [101,102]. It is important to note that such sys-
tems are developed to mimic one or more functions of an organ or
tissue rather than total physiology, as is demonstrated by systems
representing functions of cardiac, neuronal or hepatic tissue below.
In 2010, Carrion et al. [96] described a recreation of the perivas-
cular niche ex vivo in a 3D microfluidic device using endothelial
cells, suspended in 2D fibrin patterned gels. In this work, the for-
mation of a primitive vascular plexus and its maturation into a
multi-layered (EC-, MSC-, and fibroblast containing) capillary net-
work with well-defined hollow lumens was observed, in response
to a compartmental segmentation in the access to nutrients. Focus-
ing on angiogenesis and thrombosis, Zheng et al. [13] proposed an
in vitro microvascular networks in 3D collagen scaffolds and
demonstrated the nonthrombotic nature of the vascular endothe-
lium, as opposed to a prothrombotic state upon induced inflamma-
tory response (Fig. 6A). Similarly, in several other studies, vascular
tissue was used as a model to develop a microfluidic setup, whichwas then used to study frequently occurring pathologies, such as
microvascular thrombosis [13,103,104], as well as angiogenesis
[105–108] or the blood–brain barrier [109–111]. Compartments
were also successfully used to mimic more physiological condi-
tions related to human vasculature. Hsu et al. [112] built a multi-
microtissue array, allowing long term co-culture of endothelial
and stromal cells, in presence of fibrin gel. By connecting each
microtissue chamber on the top and bottom edges through a long
interconnecting channel, a series of pressure dividers was created,
comparable to an electric circuit. By adjusting the length of the
channel, the magnitude of the pressure drop was adjusted. Each
chamber containing microtissue within the platform was used as
an independent experiment allowing quantification of the total
vessel length per condition tested (Fig. 6B). With vascularization
being a highly important player in the progression of many dis-
eases as well as in regenerative processes, several other studies
have employed microfluidic techniques to build 3D vascularized
tissue, as reviewed by Hasan et al. [113].
Spatial segmentation using microfluidics can also be used to
support individualized culture of aggregates and spheroids, of
either non-adherent cell types or on repellent substrates that
Fig. 7. (A) A microengineered lung-on-a-chip model of human pulmonary edema. Interleukin-2 (IL-2) induced pulmonary edema model reproducing the lung
microarchitecture and breathing-induced cyclic mechanical distortion of the alveolar-capillary interface. The top ‘‘air” portion corresponds to the alveolar channel and the
bottom ‘‘liquid” portion to the vascular channel. The phase-contrast image shows a top-down view of the apical surface of the alveolar epitheliummaintained at an air–liquid
interface in the upper microchannel (i). Scale bar, 200 lm; barrier permeability in response to IL-2, with and without cyclic strain (ii); immunostaining of epithelial occludin
(green) and vascular endothelial cadherin (VE-cadherin; red) after 3 days of cyclic stretch with 10% strain without IL-2 (control) or with IL-2. White arrows indicate
intercellular gaps; blue, nuclear stain (DAPI) (iii). (scale bars = 30 lm). Adapted from Ref. [123]. Reproduced with permission of American Association for the Advancement of
Science. (B) A model of a human vascularized organ-specific microenvironment, which can be used to investigate and tune the extravasation of metastatic tumor cells. A
schematic of the device showing siding media channels that allow supply of cancer cells, biochemical factors, and flow across the vasculature formed inside the gel channel
(i). Endothelial cells (ECs), MSCs, and osteoblast-differentiated cells (OBs) are initially seeded in the gel, where ECs form vasculature, and MSCs and OBs a bone-mimicking
microenvironment. Cancer cells introduced in the vessel extravasated into the organ-mimicking gel; the microvascular network is characterized by highly branched
structures (ii); cancer cell extravasation (iii) and ECs permeability (iv) decreased significantly in the presence of flow through the vasculature. Extravasated cancer cells
migrated further in the flow condition (v). Fluorescent actin staining (yellow) and cell nuclei staining (DAPI, blue) of ECs cultured in static condition (vi-left) and under flow
(vi-right). Adapted from Ref. [125]. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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sely mimic natural microenvironments of, for example, tumor tis-
sues, thus improving reliability and predictability of studies
evaluating efficacy of therapeutic intervention [114–117]. Given
the versatility of microfluidics, and various levels of integration,
cell culture and drug screening can in many cases be performed
in a single platform [118,119]. For example, Frey et al. [120] devel-
oped a hanging-drop platform into which cells can be directly
pipetted. The complex fluidic network can perfuse through the
hanging drops, delivering nutrients, and other compounds of inter-
est (Fig. 6C). Depending on the cell dispensing and perfusion con-
figuration, exposure to soluble gradients and parallel or closed
loop assays can be created. This system enables screening of the
effect of compounds and delivers information on communication
between individual segments of the platform as demonstrated by
a sequential culture of hepatocytes upstream of human colorectal
carcinoma cells HCT-116.
This feature of networking among compartments has probably
been most extensively explored in the field of neurobiology, where
such systems are becoming increasingly recognized as standard
experimental tools. For instance, they have been used for long term
co-cultures of hippocampal neurons and glia cells [121], or for pat-
terning of geometrically defined networks for the analysis of neu-
rodegenerative processes [122].
Based on the rationale that the brain is intrinsically complex,
highly compartmentalized, layered, and contains multiple cell lin-
eages with plastic connectivity via axon and dendrite outgrowths,
Dinh et al. [94] developed a microfluidic circuit for single neuron
arraying, combining a novel patterning technique based on plasma
stencilling with water masking. The process allowed in situ and
aligned biomaterial patterning for directional outgrowth in which
inter-compartment neuronal networks are precisely defined
(Fig. 6D).3.3. Functional organ-like models
While previously described models in general mimicked a sin-
gle, relevant function of an organ or tissue, recent developments
have focused on biomimicking microfluidic assemblies with
increased hierarchical complexity, actively actuated by external
cues, alongside with dynamic mass transfer inputs, which can
eventually produce quasi-real functional organ or tissue structures.
Probably one of the most illustrative examples of organ-on-
chips systems is the lung-on-chip device by Huh et al. [123,124],
developed with the aim to establish a human disease model of pul-
monary edema induced by drug toxicity. In this co-culture system,
the alveolar-capillary interface of the human lung was reproduced
by a multi-compartment device, with endothelial and epithelial
cells forming a monolayer on either side of a porous stretchable
membrane, that was actuated by air, like in a lung (Fig. 7A). The
system demonstrated that mechanical breathing is critical in IL-
2-induced edema, that both epithelial and endothelial gaps con-
tribute to pulmonary vascular leakage and that response to IL-2
does not require circulating immune cells. Additionally, the model
helped to identify promising new therapeutic candidates.
Recently, Jeon et al. [125] reported on the development of a new
3D microfluidic in vitro model, based on a microvascular network,
for characterization of organ-specific human breast cancer metas-
tasis into bone and muscle. The authors identified the protective
and anti-metastatic role of skeletal muscle cells and proposed
the use of this platform for tailored screening of anticancer thera-
pies in the context of personalized medicine (Fig. 7B).
Another interesting example was given by Sciancalepore et al.
[126], who developed a bio-inspired renal microdevice aiming to
simulate physiological conditions of a kidney proximal tubule.
The authors developed a tubule that was populated by adult renal
stem/progenitor cells (ARPCs) and supported by a perfused porous
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exposed to fluidic shear stress in the apical region, resulting in a
polarized expression of aquaporin-2 transporter and to a Na+K
ATPase pump located in the basolateral region. Notably, after only
four days of culture, during which a confluent cell layer was
formed, significant levels of urea and creatine could be recovered.
Another important promise of organ-like models is the ability to
mimic the systemic effects, e.g., the effects of immune system on
the progression of a disease or on the efficacy of a treatment. Fur-
thermore, organ-like compartments may be organized sequentially
to expose molecules to metabolic functions, in order to better pre-
dict their efficacy when administered systemically. In a recent
review, Polini et al. [127] highlighted the developments in integra-
tion of multiple individual organ units into a single platform. In
another review, Huh et al. [128] suggested that such integrated
models may be useful for in vitro monitoring of different routes
of drug administration (oral, aerosol and transdermal) and their
effect on drug stability. While the majority of the so far developed
organ-on-chip models have focused on study of disease progres-
sion and associated treatments methods, we recently discussed
the potential of such models to study processes of tissue and
organ-regeneration [129], and emphasized that complexity of such
model may present new, different technological challenges.4. Biomaterial production using microfluidics
As is described thus far, screening of biological phenomena and
generation of physiologically relevant biological models are by far
the most important applications of microfluidic systems in
biomedical science. Nevertheless, such systems can also be very
useful as tools for fabricating, natural or synthetic, biomaterials.
Three main applications of such microfluidics-produced biomateri-
als can be identified: delivery of (biological) compounds and/or
cells; enrichment of rare primary cells; and bioprinting [130].
Many of these systems are based on droplets, a rapidly growing
subfield within microfluidics. Droplets are finely controlled emul-
sion objects generated by microfluidic stream breaks [131,132],
existing either physically entrapped in arrays [133–135] or free
in suspension [132,136,137]. As opposed to conventional methods
to produce droplets, microfluidics-generated droplets can be
highly monodisperse, easily engineered in geometry and content,
and available for modular arrangements [131,132], owing to tech-
nical possibilities that allow precise generation, handling [138,139]
and dispensing [140–142].4.1. Biomaterials for delivery of biological compounds
While the number of therapeutic agents including antibiotics,
growth factors, small molecules and other drugs is increasing, their
efficient, controlled and targeted delivery to the body remains a
challenge. Application of small-sized particles as delivery vehicles
offers solutions for some of the challenges, including issues with
solubility of complex molecules, amounts to be delivered and con-
trol over release. Small particles can be used for surface bulk bind-
ing of the molecules, with their large specific surface area allowing
loading of large amounts and multicomponent materials with con-
trolled composition that can be used to control delivery dynamics.
Drug carrier production using microfluidic droplet generation is
considered an interesting alternative to other methods of
microparticle production such as spray-drying, as it allows produc-
tion of particles with a size below 100 nm [143,144]. In particular
structures such as polymersomes, prepared from water–oil–water
templates and having either single, or multiple hydrogel cores,
allow complex compartmentalization inside the droplets. This con-
figuration ensures stability and protection to degradation whilegranting a sustainable release through the diffusion barrier consti-
tuted by the lipid bilayer [145].
Valencia et al. [146] developed a fully integrated system, using
up to 15 different polymeric nanoparticle precursors in different
ratios, with a multi-inlet micromixer to allow for programmable
and systematic combinatorial mixing before nanoprecipitation
occurs (Fig. 8A). Further developments in this kind of platforms
may involve increased automation, bringing together digitally pro-
grammable circuits with responsive, reliable valves support
[130,147]. Droplet-fusion for combinatorial synthesis [148] and
chitosan microparticles assembly [149] are examples of extensive
possibilities that droplet generation offers in the development of
carriers for controlled delivery of biologics.
To address the issues associated with handling and preservation
of deliverable cell aggregates in the period between their produc-
tion and implantation, Cha et al. [150] used droplet technology
to develop gelatin-silica core–shell microgels as carriers of cardiac
side population (CSP) cells. While methacrylate gelatin droplets
were used as actual carriers, the silica shell acted as a protective
coating that degrades under physiological condition, once injected
into cardiac tissue.
4.2. Biomaterials for cell selection and enrichment
Besides delivery of compounds of interest, droplet
microfluidics-generated materials can also be used as carriers of
cells. As such, they not only provide a 3D matrix to the cells, but
they can also be used as individual microenvironments inside
which biological processes, such as cell proliferation, differentia-
tion, ECM production, etc. can be independently regulated [88].
Successful culture of stem cells while retaining their purity and/
or pluri- or multipotency in vitro in quantities required for clinical
use, has been one of the major challenges in the process of clinical
implementation of cell therapies. Confined 3D culture systems in
which cell–cell interactions can be controlled to a high extent are
expected to provide a significant contribution to platforms for-
high throughput culture of stem cells. The scalability of autologous
cell production may provide a strong boost to development of cell
therapy strategies, including the expansion of stem cells from
umbilical cord blood [151,152], culturing of islets of Langerhans
[153] and replacement of ventricular myocytes in case of myocar-
dial failure due to infarction [154], among other applications.
Currently, strategies for expanding stem cells include aggrega-
tion or synthetic carriers taking into account the adherent nature
of cells within a number of relevant lineages [155–157]. In general,
the basic requirements for creating a self-renewal cellular niche
includes the presence of an ECM-like environment, availability of
soluble factors, cell-to-cell contact along with mechanical forces
at microscale [156]. As mentioned earlier, hydrogels can fulfill a
number of these requirement. Therefore, microfluidic droplet for-
mation can be a valuable tool for cell encapsulation, either in an
aqueous phase or in a 3D hydrogel, enabling expansion scale-up
microenvironment fine-tuning both in composition and in mass
transfer kinetics, and release from labor-intensive replating of cell
spheroids. [158–160]. Agarwal et al. [137] developed a microen-
capsulation system for 3D culture of pluripotent stem cells aiming
to overcome 2D culture limitations. In this work, microcapsules
with an aqueous core containing ES cells inside an alginate hydro-
gel shell, were systematically produced. This system enabled cell
clustering and aggregate expansion within the construct, while
retaining their stemness, as verified by gene expression of Oct-4,
Sox2, Nanog and Klf2, as markers of pluripotency (Fig. 8B). Chan
et al. [160] applied a similar system showing an enhanced osteo-
genic differentiation of hMSC spheroids inside double-emulsion
droplets with an inner phase made of an alginate-arginine-gly
cine-aspartic acid (-RGD) hydrogel.
Fig. 8. (A) Microfluidic platform for rapid, combinatorial synthesis of nanoparticles (NPs). A schematic representation of the system where NP precursors enter a multi-inlet
mixer at different ratios producing a library of NPs upon self-assembly (i); detail showing mixing of streams (ii) (scale bar = 200 lm); image of hydrodynamic flow-focusing
where NPs self-assemble through nanoprecipitation (scale bar = 20 lm) and photograph of microfluidic devices (iii); image of representative monodisperse NPs produced in
the system (iv) (scale bar = 50 nm). Adapted with permission from [146]. Copyright 2013 American Chemical Society. (B) A core–shell microcapsule system for mimicking the
miniaturized 3D architecture of pre-hatching embryos with an aqueous liquid core of embryonic cells and a hydrogel shell of zona pellucida, developed by microfabricating a
non-planar microfluidic flow-focusing device. A schematic representation of the device for one-step generation of core–shell microcapsules from two aqueous fluids, with
detailed image of the flow-focusing junction (i); representative images showing gradual coverage of the core fluid by the shell fluid (ii); an increase in the mRNA expression of
markers of pluripotency Sox2, Nanog, and Klf2 of embryonic stem cell cultured in the device as compared to 2D culture (iii) and fluorescent staining of pluripotency marker
Oct-4 (green) and SSEA-1 (red) in ES cell aggregates (iv) (nuclei (DAPI, blue) and differential interference contrast (DIC). Adapted from Ref. [137] with permission of The Royal
Society of Chemistry. (C) A microchip system based on a combination of immunomagnetic separation and microfluidics for high-throughput detection of whole cells. A
schematic of the micro-aparture chip system, where target cells bound to magnetic beads flow parallel to a microchip with flow rates of mLs/min. Copyright 2012 IEEE.
Reprinted, with permission, from Ref. [166]. (D) Microfluidic device for single cell encapsulation inside droplets and cell electrofusion after droplets pairing. A double T-
junction enables parallel droplet generation with single cell encapsulation (i-a); coalescence of droplet pair by activation from a siding pair of electrodes generating an
electrical field (i-b); volume reduction of fused droplet by liquid suction in a pitchfork (i-c); cell fusion by electrode pair actuation across the microchannel (i-d). A grayscale
video snapshot shows the formation of droplets carrying cells and their subsequent merging (ii). Adapted with permission from [179], Copyright 2013 WILEY-VCH. (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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and regenerative medicine approaches, enrichment of rare or diffi-
cult to harvest types of cells can also be achieved using microflu-
idic tools. For example, microfluidic arrays have been used to
concentrate cells in order to support cancer cell detection with
the aim to achieve personalized early cancer prognosis based on
circulating tumor cells (CTCs) assessment of their sensitivity to
anticancer drugs [161,162]. Others have demonstrated the isola-
tion of functional cardiomyocytes from heterogenous cell mixtures
[163], leukocytes collection from blood fractions [164], and MSCs
selection from amniotic fluid [165].
Targeting the isolation of rare cells, such as CTCs, Chun-Li et al.
[166] developed a microfluidic chip for enrichment and analysis of
whole cells. In the system, the target cells, bound to immunomag-
netic beads were flown parallel to a porous wall while being actu-
ated by a magnetic field, and retrieved by disabling the magnetic
field (Fig. 8C). The system was successfully validated for detectingbreast (MCF-7) and lung (A549) cancer cells in culture reaching
yields up to 97% at 1 ml/min flow rate and a concentration as
low as 0.8 cell/ml. In a similar device setup by Cooper et al.
[167], rare pathogen cells could be detected in small volume of
human blood samples, assisted by ligand-coated magnetic beads,
but instead of being caged in microwells, they were spread into a
thin layer, allowing optical detection.
Efforts have also been invested in selection and handling of sin-
gle cells. Selective single cells isolation has become available
through the combined use of fluidic regimes and biomolecular
chemistry technologies [168], or more simply through geometrical
displacement and positioning [169]. Delicate handling of cells has
now become possible by incorporation of non-invasive techniques
such as optical tweezers [170,171] and dielectrophoresis
[172,173], or through immunomagnetic probes targeting different
cell populations [166,174,175]. Ability to select and handle single
cells allows for the use of unique derivation of genetic material
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[177–179]. For example, Schoeman et al. [179] engineered a device
capable of encapsulating single cells inside droplets generated in
parallel, which are paired in a second step and merged by the
action of an electrical field. The resulting droplet is then reduced
in volume by content suction, bringing the cells closer to one
another in order to fuse and form a hybridoma while passing
through an actuating pair of electrodes in the channel (Fig. 8D).
As summarized by Shields et al. [180], active systems for cell
sorting make use of external stimuli (e.g., acoustic, electric,
magnetic, and optical) to impose forces to displace cells, whereas
passive systems rely on inertial forces, filters, and adhesion mech-
anisms. Microfluidic devices are suitable for both types of systems,
as is demonstrated by examples of systems, utilizing geometrical
fluid barriers [181–183], hydrodynamic forces [184], filtering
methods [185], dielectric- [186–188] and magnetic material
properties [80,189], acoustics [190] and optics [191].
4.3. Building blocks for bioprinting
Additive manufacturing, also known as 3D printing, is a tech-
nology that enables building of 3D structures from natural or syn-
thetic materials. This technology has attracted much attention
because it allows high level of control over properties of the struc-
tures, at different length scales. In the early days of additive man-
ufacturing, many available techniques suffered from a limited
resolution. However, it is now possible to directly produce struc-
tures with controlled topographical features at the submicron
scale, or to perform bioprinting using single cells, clearly demon-
strating the potential value of microfluidic systems herein. A com-
bination of additive manufacturing and microfluidics can be seen
from different perspectives, including: (1) application of additive
manufacturing to build microfluidic devices for biomedical
applications; (2) building of structures inside the microfluidic
compartments, preferably prior to assembly of components, and
fluid connection; and (3) using the microfluidics as an additive
manufacturing tool.
Only few examples exist of additive manufacturing techniques
being directly used to build microfluidic devices. Hamid et al.
[192], for example, developed an integrated additive manufactur-
ing instrument to allowmultiple operations leading to direct print-
ing of cell-laden microfluidic chips. The motorized setup,
containing four heads, was capable of alternating between
dispensing of a photopolymerizable-polymer, its exposure to
UV-light and crosslinking, and dispensing of the biological content
and application of gas plasma treatment to functionalise the
surface for later bonding of the lid.
Undoubtedly, additive manufacturing, rapidly becoming an
affordable technique to many research laboratories will be more
frequently used for production of microfluidic devices in the future
[193]. Along with this, new polymers (including transparent ones,
and polymers allowing higher resolution manufacturing) suitable
for additive manufacturing, are becoming available, making this
technique a serious alternative to standard lithographic processes
for building microfluidic platforms. A representative example
was given by Erkal et al. [194], who designed a 3D printed device
with a receiving port that fits with commercially available stan-
dard electrodes to analyze the conditions and contents of the fluid
inside the device. Another design embedded a transwell plate for
sample collection to analyze oxygen tension in a stream of flowing
red blood cells, as well as measuring the level of ATP release
(Fig. 9A).
To address the challenge of vascularization within large tissue
constructs, Zhang et al. [195] employed additive manufacturing
to build a blood vessel-like microfluidic structure, which was then
embedded inside the bulk material. To this end, alginate andchitosan hydrogels were used for direct printing of the channels
with a wall thickness below 200 lm. The printed microfluidic
network was able to support media perfusion both outside and
embedded in bulk hydrogels to support cell viability.
Stereolithography is an interesting additive manufacturing
technique for producing transparent, biocompatible, fully com-
puter designed microfluidic devices for cell culture [16], although
the number of gas-permeable photopolymerizable resins is
limited.
While additive manufacturing has not been exploited to its
maximum extent for building the entire microfluidic devices, many
interesting examples exist of materials produced using additive
manufacturing that have been integrated into microfluidic plat-
forms. Snyder et al. [196] applied direct cell writing, using cell sus-
pension in Matrigel at a 1:1 ratio for drawing a pattern that was
later incorporated into a perfused microfluidic chamber. A combi-
nation of hepatocytes and epithelial cells was used in a model
where anti-radiation drug treatments were tested through the
compartments defined by the printed soft biomaterials. In another
study, Lee et al. [12] used inkjet-printed micropatterns of a com-
posite material containing biphasic calcium phosphate nanoparti-
cles and poly(D,L-lactic-co-glycolic acid) (P(D,L)LGA). This
multiplex device was built with the aim to better understand phe-
nomena governing implant-related wound healing while prevent-
ing bacterial infection. The model was shown to be useful for
monitoring the formation of mineralized ECM by osteoblasts, and
prevention of biofilm formation upon exposure of Staphylococcus
epidermidis to an antibiotic.
In addition to the so far presented examples of additive manu-
facturing techniques to build (parts of) microfluidic devices, it is
important to discuss the possibilities of the microfluidic devices
to print materials, or, at least, to provide continuous or discrete jet-
ting of materials through a coordinate control of the flow, with
droplet generation being particularly interesting in this context.
This is a logical application of microfluidics, because also this tech-
nique can offer a close control over the properties of complex (mul-
tiphase) fluidic dynamics over a diversity of sources, towards the
synthesis of chemically and structurally defined functional bioma-
terials. An interesting example of application of microfluidics to
produce functional biomaterials with tuned properties was given
by Shum et al. [197] (Fig. 9B) who synthetized mesoporous
hydroxyapatite through double emulsion droplets (used as individ-
ual microreactors), adjustable both in size and geometry. This plat-
form allowed on-demand regulation of droplet composition,
tuning therewith their porosity and compactness, and conse-
quently the homogeneity of the ceramic powder produced.
Another study, by Kitagawa et al. [198], presented a multilayered
microfluidic devices with a micronozzle array structure allowing
the production of hollow alginate hydrogel microfibers. This sys-
tem allowed culture of neuron-like PC12 cells in the parallel
regions, which proliferated and formed linear intercellular net-
works (Fig. 9C).
The ability of microfluidic systems to handle living tissue, or cell
niches, under mild-conditions, combined with well-established
hydrogel processing techniques, can be further exploited to make
microfluidic technology a key component in new bioprinting
developments involving direct deposition of cells. When employed
upstream of any type of nozzle used for additive manufacturing,
microfluidics offers the possibility to deliver more than just
single-cells as building blocks, and also more than just chemically
engineered hydrogels. Instead, as described in previous sections,
combinations of both materials can deliver more complex building
blocks for constructs produced using additive manufacturing. This
is an important consideration, as currently available additive man-
ufacturing tools for single-cell printing do not reach further than
printing of 2D patterns, despite efforts placed in improving nozzle
Fig. 9. (A) A transwell fluidic device for correlation of oxygen tension and adenosine triphosphate release. Picture of the assembled device with red blood cells being pumped
through the system. Adapted from Ref. [194] with permission of The Royal Society of Chemistry. (B) Synthesis of mesoporous hydroxyapatite using double-emulsion droplets
as microreactors. The inner drops of the double emulsion consist of an aqueous solution of calcium nitrate and phosphoric acid, as calcium and phosphate precursors,
respectively. The outer shell contains inert oil (i); optical microscope images of hydroxyapatite aggregates formed from precursor solutions with calcium nitrate and
phosphoric acid concentrations of 0.1 and 0.06 M (ii-a); 0.5 and 0.3 M (ii-b); and 1 and 0.6 M (ii-c), respectively. Adapted with permission from Ref. [197]. Copyright 2009
American Chemical Society. (C) A microfluidic device with a micronozzle array structure for developing hydrogel microfibers with complex cross-sectional morphologies to
be used for guiding network formation of neuronal cells. A schematic showing the device in which hydrogel precursor solutions with different compositions, with or without
rat pheochromocytoma (PC12) cells, are continuously introduced into the microchannel along with the buffer and gelation solutions (i); a photograph of an eight-region
hydrogel fiber (ii-a), fluorescent micrographs of four- (ii-b) and eight (ii-c) region hydrogel fiber and of a thin cross-section of an eight-region fiber (ii-d) produced in the
device (scale bar = 100 lm). Adapted from Ref. [198]. (D) A dispensing system for single oocytes using air ejection. On-chip cell enucleation and single-cell dispensing over an
array that can be used for further cell culture. Reprinted with permission from Ref. [203], Copyright 2013, AIP Publishing LLC. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
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terns have proven to be useful for single-cell genomic analysis
[199], among others [201,202]. In this context, microfluidic solu-
tions may be advantageous for separation and isolation of cells
ahead of being expelled through the nozzle orifice. For instance,
coupling impedance spectroscopy to the dispensing chip enables
a more robust detection at higher particle velocity than optical
methods [200]. Feng et al. [203] employed such technique to dis-
pense oocytes in a single-cell array for culturing and viability char-
acterization, demonstrating its further use in cloning (Fig. 9D).
Taken together, both additive manufacturing and microfluidics
are becoming increasingly recognized as useful techniques in
biomedical research, and smart combinations of the two may syn-
ergistically advance the state-of-the-art in the field.5. General conclusions and outlook
This review discussed a number of developments in the field of
microfluidics relevant to biomedical research, with an emphasis onbiomaterials. Microfluidics can support biomedical research by
either accelerating the throughput of screening, or by increasing
the complexity of in vitromodels in order to more closely resemble
the in vivo microenvironment. The development of high-
throughput and combinatorial screening of physical and chemical
cues, known to interfere in biological processes, was presented
here as an example of the important contribution of microfluidics
to the biomaterial field. Further, microfluidics offers tools for the
in-depth study of physiological processes in in vivo-like microenvi-
ronments, a feature that is not possible using conventional cell cul-
ture approaches. Lastly, microfluidic systems are intensively
explored as microfactories for novel, complex, synthetic or natural
biomaterials, or combinations thereof.
It is important to note that microfluidics, originating from the
field of MEMS, is a strongly technology-driven development. Tech-
nological advancements in the field of microfluidics progress at a
pace that the typically conservative biomedical field struggles to
match. This may, in part, explain why microfluidic devices have
not yet caused a paradigm shift in the way biomedical research
is executed, despite almost endless technological possibilities.
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reached a high level of maturity, with numerous companies pro-
ducing microfluidic devices for well-established applications, such
as high-throughput compound analyzes and rapid diagnostic tests.
Although examples exist of such platforms that are also used in the
biomedical field in a relatively standard manner, such as for
cell sorting, concentration, etc. [204–208], they are still scarce
and lack mainstream applications to trigger extensive industry
involvement.
As a result of the mismatch between the technological advance-
ments and the actual implementation of microfluidic systems, the
approach towards the development of new systems is now chang-
ing from ‘‘we make it because we can” to ‘‘we make it because the
need exists”. This, however, requires a truly multidisciplinary
approach to the design, whereby the input from the end-users is
of fundamental importance. On the other hand, researchers in
the biomedical field, such as biomaterials, are facing a situation
in which new clinical treatments have to be more efficient, and
developed more rapidly, both at the same time. This directly
implies that the existing research tools are not sufficient anymore,
and that new tools need to be developed. We envision that in the
future, combined efforts from the fields of microfluidics and
biomedical technology will revolve around the development of
systems that offer both a better predictability for the in vivo situa-
tion, and an increased screening throughput.
The first steps towards this aim have been made. The unique
ability of microfluidic systems to allow cell culture inside immo-
bilised hydrogels for highly stratified tissue-like constructs, along
with fine control over supplying fluidics, and complex structural
layering, makes closer mimicking of an in vivo microenvironment
a reality. In addition to compartmentalization, controlled intercon-
nection between compartments allows for the study of systemic
effects, something that is not possible with any other in vitro plat-
form. Therefore, current organ-on-chip models are not only useful
for studying malfunctioning of a single component of an organ, and
its associated drug therapy, but they also enable studying of com-
plex process such as tumor metastasis and regeneration using dif-
ferent strategies.
An important issue that remains a challenge in such systems is
the availability of adequate and reliable readouts. Due to the low
handling volumes required for microfluidics, the large majority of
conventional quantitative methods used as standards in molecular
cell biology are not directly applicable to such microsystems. In
microfluidic systems, conventional quantitative techniques often
operate at the lower limits of sensitivity. Furthermore, it is difficult
to retrieve a sample or to integrate a sensor, and even when this is
possible, valuable spatial information is lost. Attempts have been
made to adapt the conventional analytical techniques to the
requirements of microfluidics, for example by developing cus-
tomized interfaces, or by the use of single-cell or low cell number
genomic or proteomic analyzes [5,209,210]. However, microfluidic
platforms, as with many other high-throughput screening plat-
forms, will continue to largely rely on biomolecular engineering
techniques coupled with microscopy-based imaging. Although
downscaling of assays is a big challenge, the possibility to perform
experiments with a much higher throughput in microfluidic
devices is one part of the solution. In any case, researchers in the
biomedical field will need to accept that alternative readouts are
inherently connected to microfluidics-based systems. This is
probably only a matter of time, once the evidence for validity
and reliability of such alternative assays is provided. On the
other hand, small volumes and low amounts of materials/cells
offers new possibilities for personalized medicine, where clinically
relevant microfluidic in vitro models will be developed with
patient’s own cells, or specific combinations of genetic mutations,
etc.We also expect that biomaterial development will further ben-
efit from the application of microfluidics, alone and in combination
with other production systems. In particular, microfluidic systems
are expected to aid development of biomaterials with closely
controlled properties. Microfluidics will not only be used for the
relatively simple generation of gradients within hydrogels, but its
use will extend to other material types with various levels of
physico-chemical complexity. This will require development of
more modular systems, where biomaterials can be introduced into
the system using other techniques prior to the assembly of the
platform. Such examples include micromolding in capillaries,
photolithography, two-photon polymerization, fiber growth,
cellular textile mono- and multi-layers, spheroids, etc.
Furthermore, hybrid set-ups, combining microfluidic parts such
as cell-supporting hydrogel constructs, and robotic components
from 3D printers, such as combinatorial nozzle platforms, may
enable the construction of realistic, hierarchical macroscale func-
tional living tissue mimics. Together with the integration of other
biomaterial components, ranging from protein aggregates, poly-
mers, or ceramics, into such mimics, it is very likely that robust
in vivo disease and regenerative models will be further developed.
Furthermore, one can envision that such sophisticated mimics
would also become available as implantable constructs.
In summary, this review has shown that the developments in
the field of microfluidics are not solely technical advancements,
but are also truly valuable tools for biomedical research. Therefore,
it is conceivable that they may in the future successfully replace
the minimalistic gold standard of flat plastic substrates supporting
monolayer cultures. To this end, such systems will have to become
more accessible to the average research laboratory. Needless to
mention, these developments will also lead to new challenges, in
particular when it comes to the availability of reliable assays. Fur-
thermore, the predictive value of any future screening system will
need to have a proven higher level of output information than
what conventional, simpler systems currently offer. We believe
that a more collaborative development of new platforms, with
microfluidics engineers as technology providers, and biomedical
scientists as users, is imperative for reaching this goal.
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